Lufax Faces Securities Class Action Lawsuit
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Apr 08 2026
0mins
Should l Buy LU?
Source: Globenewswire
- Lawsuit Background: Lufax announced the removal of its auditor on January 27, 2025, due to concerns over undisclosed related-party transactions, triggering a nearly 14% drop in share price that day, highlighting severe investor concerns regarding the company's financial transparency.
- Internal Control Deficiencies: The class action alleges that Lufax lacked adequate internal controls and that its financial results were materially misstated, affecting investors who purchased securities between April 7, 2023, and January 26, 2025, indicating a significant weakness in corporate governance.
- Auditor Opinion Rejection: PwC refused to include its prior audit opinions in any current or future company filings, indicating a loss of trust in Lufax's 2022 and 2023 financial statements, which could further erode investor confidence in the company's future financial health.
- Investigation Progress: Hagens Berman is investigating whether Lufax intentionally violated accounting rules and disclosure requirements, and if confirmed, such misconduct could lead to greater legal and financial repercussions for the company.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy LU?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on LU
About LU
LUFAX HOLDING LTD is a holding company mainly engaged in providing financial services for small and micro enterprises. The Company's core retail credit enablement business includes bank-funded loans, trust-funded loans and consumer finance loans. The Company is also engaged in wealth management and providing access to financial products and services. The Company conducts the business through its subsidiaries.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- Lawsuit Background: Lufax announced the removal of its auditor on January 27, 2025, due to concerns over undisclosed related-party transactions, triggering a nearly 14% drop in share price that day, reflecting severe market skepticism regarding the company's financial transparency.
- Lack of Financial Controls: The class action alleges that Lufax lacked adequate internal controls and that certain financial results were materially misstated, severely undermining investor trust in the company's financial reporting and potentially impacting future fundraising capabilities.
- Auditor Opinion Refusal: PwC refused to consent to the incorporation of its prior audit opinions in any current or future company filings, indicating a loss of trust in Lufax's 2022 and 2023 financial statements, which exacerbated investor anxiety.
- Investigation and Compensation: Hagens Berman is investigating whether Lufax intentionally violated accounting rules, urging investors who suffered significant losses to submit claims, highlighting deep concerns over corporate governance and compliance.
See More
- Class Action Initiated: Bronstein, Gewirtz & Grossman LLC has filed a class action lawsuit against Lufax and its executives, seeking damages for investors who purchased securities between April 7, 2023, and January 26, 2025, highlighting serious concerns over corporate governance and financial transparency.
- Allegations Overview: The complaint alleges that Lufax lacked adequate internal controls and materially misstated financial results during the class period, resulting in misleading statements about the company's business and prospects, which could significantly impact investor decisions.
- Investor Participation: Affected investors have until May 20, 2026, to request to be appointed as lead plaintiff, emphasizing the importance of legal recourse in protecting investor rights and potential recovery of losses.
- Law Firm Credentials: Bronstein, Gewirtz & Grossman LLC is recognized for recovering hundreds of millions for investors, underscoring its expertise in securities fraud class actions and commitment to upholding market integrity and accountability.
See More
- Class Action Filed: Pomerantz LLP has announced a class action lawsuit against Lufax, alleging securities fraud and other unlawful business practices by the company and certain officers, with investors urged to apply as Lead Plaintiff by May 20, 2026, highlighting serious governance concerns.
- Auditor Change Controversy: On January 27, 2025, Lufax proposed to replace its auditor, PricewaterhouseCoopers, due to significant concerns regarding the financial disclosures in its 2022 and 2023 Annual Reports, indicating a crisis in the company's financial transparency.
- Stock Price Volatility: Following the auditor change announcement, Lufax's American Depositary Shares fell nearly 22% over three trading sessions, a drastic decline that not only undermines investor confidence but may also negatively impact the company's future financing capabilities.
- Law Firm's Reputation: Pomerantz LLP is a prominent securities class action law firm with over 85 years of experience, focusing on advocating for victims of securities fraud, and its successful track record underscores its expertise and influence in the field.
See More
- Class Action Notice: Rosen Law Firm reminds investors who purchased Lufax securities between April 7, 2023, and January 26, 2025, that they must apply to be lead plaintiff by May 20, 2026, to participate in the class action and seek compensation.
- Lawsuit Background: The lawsuit alleges that Lufax failed to disclose inadequate internal controls and materially misstated financial results during the class period, resulting in investor losses when the truth emerged, which negatively impacted the company's reputation and investor confidence.
- Law Firm Credentials: Rosen Law Firm specializes in securities class actions and has achieved the largest securities class action settlement against a Chinese company, demonstrating its expertise and successful track record, thereby enhancing investor trust.
- Participation Instructions: Investors can visit the Rosen Law Firm website or call the toll-free number for more information, ensuring they select qualified legal counsel to effectively protect their rights.
See More
- Legal Investigation Launched: Faruq & Faruqi LLP is investigating potential claims against Lufax Holding Ltd., particularly for investors who purchased or acquired securities between April 7, 2023, and January 26, 2025.
- Investor Rights Reminder: The firm reminds investors that May 20, 2026, is the deadline to seek the role of lead plaintiff in a federal securities class action, highlighting the urgency and potential legal ramifications of the case.
- Direct Contact Channels: Investors who have suffered losses are encouraged to contact Josh Wilson, a partner at Faruq & Faruqi, directly at 877-247-4292 or 212-983-9330 (Ext. 1310) for consultation.
- Impact of Legal Action: This investigation may negatively affect Lufax's stock price and investor confidence, especially as the company faces a class action lawsuit, potentially leading to greater legal and financial risks.
See More
- Class Action Notice: Lufax (NYSE: LU) investors are reminded of an upcoming securities fraud class action lawsuit concerning shares purchased between April 7, 2023, and January 26, 2025, urging those who suffered losses during this period to take note of the impending legal action.
- Lawsuit Details: Filed in the U.S. District Court for the Central District of California, the lawsuit alleges that Lufax and certain senior officers violated the Securities Exchange Act of 1934, claiming that misrepresentations regarding the company's internal controls led to materially misstated financial results, potentially impacting investor recovery rights.
- Lead Plaintiff Requirements: Investors wishing to serve as lead plaintiffs must file necessary documents by May 20, 2026, with the lead plaintiff representing other class members in directing the litigation, while those opting not to participate can still share in any potential recovery.
- Legal Fee Structure: All representation is on a contingency fee basis, meaning shareholders incur no fees or expenses, which reduces the financial burden on investors and encourages more affected shareholders to take action.
See More











